Takeda Exercises Option to Acquire Adaptate Biotherapeutics
By Sasha Yachu
Pharma Deals Review: Vol 2022 Issue 1 (Table of Contents)
Published: 29 Jan-2022
DOI: 10.3833/pdr.v2022.i1.2666 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a move to bolster its immuno-oncology portfolio, Takeda Pharmaceutical has exercised its option to acquire Adaptate Biotherapeutics for an undisclosed amount...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS